Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Hemolytic Disease (Cold Type) (Warm Type)”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT03226678
What this trial is testing

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Who this might be right for
Warm Autoimmune Hemolytic AnemiaCold Agglutinin Disease
Apellis Pharmaceuticals, Inc. 24
Not applicableLooking for participantsNCT07019038
What this trial is testing

National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic AnemiaAutoimmune Hemolytic Anemia Mixed Type
Institute of Hematology & Blood Diseases Hospital, China 9,999
Testing effectiveness (Phase 2)Study completedNCT01345708
What this trial is testing

A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 23